Skip to main content
NCBI home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1996 Sep 1;495(Pt 2):525–534. doi: 10.1113/jphysiol.1996.sp021612

Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.

A Bischoff 1, W Erdbrügger 1, J Smits 1, M C Michel 1
PMCID: PMC1160810  PMID: 8887762

Abstract

1. Neuropeptide Y (NPY) has been reported to enhance diuresis and natriuresis in anaesthetized rats although it is a potent renal vasoconstrictor in vitro in vivo in several species. Therefore, we have investigated anaesthetized rats to see whether reduction in renal blood flow (RBF) and enhancement of diuresis and natriuresis can occur concomitantly, and how diuresis and natriuresis might be enhanced despite reduced RBF. 2. Systemic or intrarenal NPY infusion (0.03-3 micrograms kg-1 min-1) had only a small effect on mean arterial pressure (maximal increase 15-20 mmHg) and heart rate (maximal decrease 30 beats min-1) but dose-dependently reduced RBF (maximal peak reduction 3 ml min-1) Endogenous creatinine clearance was not significantly altered. 3. In anaesthetized rats systemic infusion of 1 or 3 micrograms kg-1 min-1 NPY enhanced urine formation and sodium and calcium excretion by a maximum of 110, 110 and 45%, respectively, but did not alter potassium excretion. Enhancement of diuresis was also detectable in conscious rats. 4. The diuretic and natriuretic effects of systemically infused NPY were at least partly maintained in rats with decapsulated kidneys and in rats where NPY-induced increase of renal perfusion pressure was excluded mechanically by an adjustable clamp placed on the abdominal aorta. 5. Intrarenal infusion of 0.3 or 1 microgram kg-1 min-1 NPY reduced RBF to a greater extent than systemic infusion (maximal peak reduction 4 ml min-1) but caused a smaller enhancement or even a reduction of urine formation and sodium excretion. 6. We conclude that systemic infusion of NPY reduces RBF by a direct effect on the renal vasculature. Systemic NPY infusion enhances urine formation and sodium and calcium excretion. This occurs independently (at least in part) of pressure natriuresis by formation and/or release of an extrarenal factor which might act on distal tubules and/or collecting ducts.

Full text

PDF
525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. M., Raine A. E., Ledingham J. G., Bloom S. R. Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci (Lond) 1985 Apr;68(4):373–377. doi: 10.1042/cs0680373. [DOI] [PubMed] [Google Scholar]
  2. Ballesta J., Polak J. M., Allen J. M., Bloom S. R. The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPY. Histochemistry. 1984;80(5):483–485. doi: 10.1007/BF00495438. [DOI] [PubMed] [Google Scholar]
  3. Dietrich M. S., Fretschner M., Nobiling R., Persson P. B., Steinhausen M. Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity. J Physiol. 1991 Dec;444:303–315. doi: 10.1113/jphysiol.1991.sp018879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Echtenkamp S. F., Dandridge P. F. Renal actions of neuropeptide Y in the primate. Am J Physiol. 1989 Apr;256(4 Pt 2):F524–F531. doi: 10.1152/ajprenal.1989.256.4.F524. [DOI] [PubMed] [Google Scholar]
  5. Firth J. D., Raine A. E., Ledingham J. G. The mechanism of pressure natriuresis. J Hypertens. 1990 Feb;8(2):97–103. doi: 10.1097/00004872-199002000-00001. [DOI] [PubMed] [Google Scholar]
  6. Hackenthal E., Aktories K., Jakobs K. H., Lang R. E. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am J Physiol. 1987 Mar;252(3 Pt 2):F543–F550. doi: 10.1152/ajprenal.1987.252.3.F543. [DOI] [PubMed] [Google Scholar]
  7. Knight D. S., Fabre R. D., Beal J. A. Identification of noradrenergic nerve terminals immunoreactive for neuropeptide Y and vasoactive intestinal peptide in the rat kidney. Am J Anat. 1989 Mar;184(3):190–204. doi: 10.1002/aja.1001840303. [DOI] [PubMed] [Google Scholar]
  8. Le Noble J. L., Struyker-Boudier H. A., Smits J. F. Differential effects of general anesthetics on regional vasoconstrictor responses in the rat. Arch Int Pharmacodyn Ther. 1987 Sep;289(1):82–92. [PubMed] [Google Scholar]
  9. Michel M. C. Rapid desensitization of adrenaline- and neuropeptide Y-stimulated Ca2+ mobilization in HEL-cells. Br J Pharmacol. 1994 Jun;112(2):499–504. doi: 10.1111/j.1476-5381.1994.tb13101.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Minson R., McRitchie R., Chalmers J. Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit. J Auton Nerv Syst. 1989 Jul;27(2):139–146. doi: 10.1016/0165-1838(89)90095-7. [DOI] [PubMed] [Google Scholar]
  11. Oellerich W. F., Malik K. U. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney. J Pharmacol Exp Ther. 1993 Sep;266(3):1321–1329. [PubMed] [Google Scholar]
  12. Pernow J., Lundberg J. M. Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):379–385. doi: 10.1007/BF00167038. [DOI] [PubMed] [Google Scholar]
  13. Pernow J., Lundberg J. M. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig. Acta Physiol Scand. 1989 Aug;136(4):507–517. doi: 10.1111/j.1748-1716.1989.tb08696.x. [DOI] [PubMed] [Google Scholar]
  14. Persson P. B., Ehmke H., Nafz B., Lang R., Hackenthal E., Nobiling R., Dietrich M. S., Kirchheim H. R. Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs. J Physiol. 1991 Dec;444:289–302. doi: 10.1113/jphysiol.1991.sp018878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Romero J. C., Knox F. G. Mechanisms underlying pressure-related natriuresis: the role of the renin-angiotensin and prostaglandin systems. State of the art lecture. Hypertension. 1988 Jun;11(6 Pt 2):724–738. doi: 10.1161/01.hyp.11.6.724. [DOI] [PubMed] [Google Scholar]
  16. Smits J. F., Kasbergen C. M., van Essen H., Kleinjans J. C., Struyker-Boudier H. A. Chronic local infusion into the renal artery of unrestrained rats. Am J Physiol. 1983 Feb;244(2):H304–H307. doi: 10.1152/ajpheart.1983.244.2.H304. [DOI] [PubMed] [Google Scholar]
  17. Smyth D. D., Blandford D. E., Thom S. L. Disparate effects of neuropeptide Y and clonidine on the excretion of sodium and water in the rat. Eur J Pharmacol. 1988 Jul 26;152(1-2):157–162. doi: 10.1016/0014-2999(88)90848-5. [DOI] [PubMed] [Google Scholar]
  18. el Din M. M., Malik K. U. Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin. J Pharmacol Exp Ther. 1988 Aug;246(2):479–484. [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES